Dec 31, 2022

Enliven Therapeutics Q4 2022 Earnings Report

EPS
-$0.08
Previous year: -$2.12
-96.2%
Cash and Equivalents
$75.5M
Previous year: $90.3M
-16.3%
Total Assets
$83.3M
Previous year: $93.6M
-11.1%

Enliven Therapeutics

Enliven Therapeutics